Reducing Epitope Spread during Affinity Maturation of an Anti-Ganglioside GD2 Antibody
Authors:
Open Access
- 1 November 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 183 (9) , 5748-5755
Abstract
Ab affinity maturation in vivo is always accompanied by negative selection to maintain Ag specificity. In contrast, in vitro affinity maturation can lead to epitope spread, resulting in loss of specificity. Anti-ganglioside-GD2 mAbs are clinically effective against neuroblastoma; pain and neuropathy are major side effects. We used structural relatives of GD2 to define epitope spread during in vitro affinity maturation of an anti-GD2 single-chain variable fragment (scFv) called 5F11-scFv. Clonal dominance identified by polyclonal sequencing was confirmed by analyzing individual clones. Affinity-matured mutations were introduced into scFv-streptavidin for functional studies. Without a negative selector, 19-fold affinity improvement (clone Q, where Q is the symbol for glutamine) was associated with strong cross-reactivity with GM2 and GD1b and moderate cross-reactivity with GD3, resulting in positive immunohistochemical staining of all 13 non-neural normal human tissues, in contrast to none of 13 tissues with parental clone P. With GM2 as a negative selector, clone Y (where Y is the symbol for tyrosine) was generated with only weak cross-reactivity with GD1b, adrenal and thyroid glands, and no staining of other non-neural normal tissues. Even though there was only a 3-fold affinity improvement, clone Y showed significantly higher tumor uptake over parental clone P (134%, p = 0.04), whereas clone Q was inferior (54% of clone P; p = 0.05) as confirmed by tumor-to-normal tissue ratios across 16 organs (41% of clone P; p < 0.0001). Using the less efficient negative selector GD3, a clone mixture (Q, V, and Y, where V is the symbol for valine) emerged. We conclude that epitope spread during affinity maturation can be reduced by negative selection. Furthermore, efficiency of the negative selector depends on its cross-reactive affinity with the matured scFv.Keywords
This publication has 26 references indexed in Scilit:
- B Cells and Immunological ToleranceJournal of Investigative Dermatology, 2009
- Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Disialoganglioside Directed Immunotherapy of NeuroblastomaCancer Investigation, 2007
- Epitope spreading within lupus-associated ribonucleoprotein antigensClinical Immunology, 2005
- Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8Biochemical and Biophysical Research Communications, 2005
- Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndromeOrganic & Biomolecular Chemistry, 2004
- Negative selection — clearing out the bad apples from the T-cell repertoireNature Reviews Immunology, 2003
- Negative selection of lymphocytesCell, 1994
- A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2aCancer Immunology, Immunotherapy, 1992
- Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cellBiochemical and Biophysical Research Communications, 1985